M&T Bank Corporation vs Viatris Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: M&T Bank Corporation is the larger of the two by market cap, and Viatris Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| MTB | VTRS | |
|---|---|---|
Market Cap | $36.15B | $19.79B |
Sector | Financials | Health |
52-Week High | $254.04 | $17.39 |
52-Week Low | $178.63 | $8.74 |
Dividend Yield | 2.41% | 2.83% |
Enterprise Value | — | $32.00B |
Trailing returns across standard periods
Latest headlines on both assets
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →